Search Results - "Ying, Anita"

Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine by Castellanos, Luz E, Zafereo, Mark E, Sturgis, Erich M, Wang, Jennifer R, Ying, Anita K, Waguespack, Steven G

“…Pediatric papillary thyroid carcinoma (PTC) is usually treated with total thyroidectomy followed by radioactive iodine (RAI). Recently, RAI is being used more…”
Get full text

Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience by Dadu, Ramona, Shah, Komal, Busaidy, Naifa L, Waguespack, Steven G, Habra, Mouhammad A, Ying, Anita K, Hu, Mimi I, Bassett, Roland, Jimenez, Camilo, Sherman, Steven I, Cabanillas, Maria E

“…Context: Vemurafenib, a selective BRAF inhibitor, appears to have promising clinical activity in patients with papillary thyroid cancer (PTC) harboring the…”
Get full text

Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades by Hensley, Sarah G, Hu, Mimi I, Bassett, Roland L, Ying, Anita K, Zafereo, Mark E, Perrier, Nancy D, Busaidy, Naifa L, Hyde, Samuel M, Grubbs, Elizabeth G, Waguespack, Steven G

“…Abstract Context Sporadic medullary thyroid carcinoma (sMTC) rarely occurs in childhood and no studies have specifically focused on this entity. Objective To…”
Get full text

Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience by Dadu, Ramona, Shah, Komal, Busaidy, Naifa L, Waguespack, Steven G, Habra, Mouhammad A, Ying, Anita K, Hu, Mimi I, Bassett, Roland, Jimenez, Camilo, Sherman, Steven I, Cabanillas, Maria E

“…Vemurafenib, a selective BRAF inhibitor, appears to have promising clinical activity in patients with papillary thyroid cancer (PTC) harboring the BRAF(V600E)…”
Get full text

Role of Salvage Targeted Therapy in Differentiated Thyroid Cancer Patients Who Failed First-Line Sorafenib by Dadu, Ramona, Devine, Catherine, Hernandez, Mike, Waguespack, Steven G, Busaidy, Naifa L, Hu, Mimi I, Jimenez, Camilo, Habra, Mouhammad A, Sellin, Rena V, Ying, Anita K, Cote, Gilbert J, Sherman, Steven I, Cabanillas, Maria E

“…Context: Sorafenib, a tyrosine kinase inhibitor, is a common first-line therapy for advanced differentiated thyroid cancer (DTC). However, responses are not…”
Get full text

Cushing Syndrome Secondary to Ectopic Adrenocorticotropic Hormone Secretion: The University of Texas MD Anderson Cancer Center Experience by EJAZ, Shamim, VASSIIOPOULOU-SELLIN, Rena, BUSAIDY, Naifa L, HU, Mimi I, WAGUESPACK, Steven G, JIMENEZ, Camilo, YING, Anita K, CABANILLAS, Maria, ABBARA, Maher, AMIR HABRA, Mouhammed

“…Cushing syndrome (CS) secondary to ectopic adrenocorticotropic hormone (ACTH) secretion (EAS) has been described in association with a variety of tumors. The…”
Get full text

Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? by Cooper, Amanda B., Habra, Mouhammed Amir, Grubbs, Elizabeth G., Bednarski, Brian K., Ying, Anita K., Perrier, Nancy D., Lee, Jeffrey E., Aloia, Thomas A.

“…Background For patients with known or suspected adrenocortical carcinoma (ACC), considerable controversy exists over the use of laparoscopic adrenalectomy. The…”
Get full text

Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center by Torres, Harrys A, Mustafayev, Khalis, Juneau, Ruston P, Hwang, Jessica P, Wang, Lan Sun, Angelidakis, Georgios, Hawk, Ernest, Granwehr, Bruno P, Yepez Guevara, Eduardo, Ying, Anita K

“…The prevalence of chronic hepatitis C virus (HCV) infection in the United States is ≤1%. Universal HCV screening is recommended nationwide. Here we describe…”
Get more information

Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines by Jozaghi, Yelda, Zafereo, Mark E., Perrier, Nancy D., Wang, Jennifer R., Grubbs, Elizabeth, Gross, Neil D., Fisher, Sarah, Sturgis, Erich M., Goepfert, Ryan P., Lai, Stephen Y., Best, Conor, Busaidy, Naifa L., Cabanillas, Maria E., Dadu, Ramona, Gagel, Robert F., Habra, Mouhammed A., Hu, Mimi I., Jimenez, Camilo, Sherman, Steven I., Thosani, Sonali, Varghese, Jeena, Waguespack, Steven G., Weitzman, Steven, Ying, Anita K., Graham, Paul H.

“…Background In the face of the COVID‐19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American…”
Get full text

Update on Medullary Thyroid Cancer by Hu, Mimi I., MD, Ying, Anita K., MD, Jimenez, Camilo, MD

“…Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, demonstrating variable behavior from indolent disease to highly aggressive, progressive…”
Get full text

Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer by Cabanillas, Maria E., Williams, Michelle D., Gunn, G. Brandon, Weitzman, Steven P., Burke, Laura, Busaidy, Naifa L., Ying, Anita K., Yiin, Yeh Hung, William, William N., Lu, Charles, Lai, Stephen Y.

“…Background Anaplastic thyroid cancer (ATC) is a highly aggressive thyroid cancer. Several treatment trials are available, but the number of eligible patients…”
Get full text

Steroid Cell Ovarian Tumor in a Case of von Hippel-Lindau Disease: Demonstrating Lipid Content of the Mass with MR Imaging by Morani, Ajaykumar C., Mubarak, Ahmad Iyad, Bhosale, Hrishabh R., Ramani, Nisha S., Waguespack, Steven G., Ying, Anita

Get full text

Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma by Xu, Jian Yu, Murphy, William A, Milton, Denái R, Jimenez, Camilo, Rao, Sarika N, Habra, Mouhammed Amir, Waguespack, Steven G, Dadu, Ramona, Gagel, Robert F, Ying, Anita K, Cabanillas, Maria E, Weitzman, Steven P, Busaidy, Naifa L, Sellin, Rena V, Grubbs, Elizabeth, Sherman, Steven I, Hu, Mimi I

“…Context: Bone metastases (BM) can lead to devastating skeletal-related events (SREs) in cancer patients. Data regarding medullary thyroid carcinoma (MTC) with…”
Get full text

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation by Jasim, Sina, Ying, Anita K, Waguespack, Steven G, Rich, Thereasa A, Grubbs, Elizabeth G, Jimenez, Camilo, Hu, Mimi I, Cote, Gilbert, Habra, Mouhammed Amir

“…Most cases of multiple endocrine neoplasia type 2B (MEN-2B) are attributable to a germline methionine to threonine mutation at codon 918 (M918T) of the RET…”
Get more information

Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? by Grubbs, Elizabeth G., MD, Waguespack, Steven G., MD, Rich, Thereasa A., MS, CGC, Xing, Yan, MD, PhD, MS, Ying, Anita K., MD, Evans, Douglas B., MD, Lee, Jeffrey E., MD, Perrier, Nancy D., MD

“…Background In 2009, the American Thyroid Association (ATA) published consensus guidelines for timing of prophylactic thyroidectomy (PrThy) for treatment of…”
Get full text

Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy by Morris, Lilah F., MD, Waguespack, Steven G., MD, Warneke, Carla L., MS, Ryu, Haengrang, MD, Ying, Anita K., MD, Anderson, Barbara J., PhD, Sturgis, Erich M., MD, MPH, Clayman, Gary L., MD, Lee, Jeffrey E., MD, Evans, Douglas B., MD, Grubbs, Elizabeth G., MD, Perrier, Nancy D., MD, FACS

“…Background We investigated the incidence and impact of postoperative complications in children who underwent total thyroidectomy (TTx). Methods The records of…”
Get full text

Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening by Morris, Lilah F., Waguespack, Steven G., Edeiken-Monroe, Beth S., Lee, Jeff E., Rich, Thereasa A., Ying, Anita K., Warneke, Carla L., Evans, Douglas B., Perrier, Nancy D., Grubbs, Elizabeth G.

“…Background American Thyroid Association (ATA) guidelines suggest that thyroidectomy can be delayed in some children with multiple endocrine neoplasia syndrome…”
Get full text

Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer by Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.

“…Background. Sorafenib has proven efficacy in advanced differentiated thyroid cancer (DTC), but many patients must reduce the dose or discontinue treatment…”
Get full text

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY by Lairmore, Terry C, Diesen, Diana, Goldfarb, Melanie, Milas, Mira, Ying, Anita K, Sharma, Jyotirmay, McIver, Bryan, Wong, Richard J, Randolph, Greg

Get more information

Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes by Ying, Anita K, Lairson, David R, Giardino, Angelo P, Bondy, Melissa L, Zaheer, Irum, Haymond, Morey W, Heptulla, Rubina A

“…Ying AK, Lairson DR, Giardino AP, Bondy ML, Zaheer I, Haymond MW, Heptulla RA. Predictors of direct costs of diabetes care in pediatric patients with type 1…”
Get full text